Xiaoqiong Li, Ke Jiang, Huowang Zheng, Chenyu Zhao, Jinjun Li, Yuling Li, Xiangyu Bian, Jun Du, Liang Chen, Zhigang Zhu, Li Wang, Xiaolong Ji, Hongzhou Cui
This study evaluated the digestion and fermentation characteristics of PZMP3, polysaccharide rich in galacturonic acid purified from Z. jujuba cv. Muzao , and its modulatory effects on the gut microbiota and associated metabolites. In vitro simulated gastrointestinal digestion confirmed that PZMP3 resisted enzymatic hydrolysis in the upper gastrointestinal tract and reached the colon intact. During subsequent fecal fermentation with human microbiota (using inulin as a positive control), PZMP3 was degraded by gut microbiota, leading to a gradual reduction in pH and a substantial increase in short-chain fatty acids (SCFAs), reaching a total concentration of 142.06 ± 0.58 mmol/L at 48 h. After digestion and glycolysis, the overall trend of gases shows an increase, while H 2 S is inhibited. Microbiota analysis revealed that PZMP3 selectively promoted the proliferation of Firmicutes and Bifidobacterium while Klebsiella and Bacteroides are inhibited. Metabolomic profiling further demonstrated enriched pathways related to bile acids and amino acids, indicating its potential role in regulating host metabolic homeostasis. These findings could highlight the potential of PZMP3 as a gut-targeted functional ingredient for improving intestinal health. • Experimental design of in vitro fermentation of PZMP3. • Evaluate the dynamics of pH, gases, SCFAs, gut microbes and metabolites. • Correlate and analyze the effects of gut microbes and metabolites.